OCEA Ocean Biomedical Inc Total Asset Value of Company
The competitive advantage of Ocean Biomedical, Inc. (OCEA) is speculative due to its reliance on external investments and serendipitous discoveries. The business's success is based on the commercialization of university patents targeting cancer and malaria. This chart of total assets recorded a value of 0.00. Meanwhile, the company minimizes capital expenditures by outsourcing drug development and production to third-party contractors.
Analytical breakdowns and data insights for company Ocean Bio (OCEA)
- market value and analyst target forecast:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Ocean Biomedical, Inc.|OCEA - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Ocean Biomedical Corp|OCEA - Company Aggregate Debts|Debts to Book Capitalization Ocean Biomedical Corp|OCEA - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Ocean Biomedical|Interim Coverage Ratio oceanbiomedical.com
- net income and valuation multiples indicators:
Fundamental valuation:Ocean Biomedical, Inc.
Based on the lean staffing and academic partnerships of Ocean Biomedical, Inc. (OCEA), the total asset dynamics—reverse-calculated via ROA as the sum of liabilities and equity—reflect the actual scale of the company's resources, where local chart fluctuations serve as an indicator of portfolio volatility and necessitate an analysis of the debt structure for an objective assessment of the issuer's financial stability.
Key competitors
argenx.com (ARGX) - Company Total Assets|Aggregate Company Assets BioNTech|Abivax - Total Asset Value of Company|Company Total Assets ADMA|PTGX (Protagonist Corp) - Aggregate Asset Value|Company Total Assets IMVT (Immunovant, Inc.)|Company Total Assets kiniksa.com KNSA|GRFS - Aggregate Company Assets|Aggregate Asset Value ADPT (Adaptive Biotech)|Celldex (CLDX) - Aggregate Company Assets|Cumulative Company Assets Aurinia Corp|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com|Cumulative Company Assets DNTH (Dianthus Therapeutics, Inc.)|PHVS (Pharvaris NV) - Aggregate Asset Value|Company Total Assets ABCL (abcellera.com)|Company Total Asset Base Tourmaline (TRML)|PGEN - Aggregate Company Assets|pharming.com (PHAR) - Cumulative Company Assets|Nektar Therapeutics Inc. (NKTR) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|Cumulative Company Assets ZBIO|Company Total Assets Immunome Bio|Aggregate Company Assets Gossamer Bio, Inc. (GOSS)|kalvista.com - Total Business Assets|Company Total Assets SEPN (Septerna)|Pieris Pharma (PVLA) - Company Assets|SVRA - Aggregate Company Assets|Company Assets Rigel Corp|ANAB: Company Total Assets|Cumulative Company Assets astriatx.com|ENGN (enGene) - Company Total Assets|Company Assets RAPT Therapeutics Inc. RAPT|Company Total Assets JBIO|Company Total Assets Aclaris Therapeutics, Inc (ACRS)|Aggregate Company Assets Kyverna Therapeutics KYTX|TLSA: Total Business Assets|CABA: Cumulative Company Assets|Aggregate Asset Value VTYX (Ventyx Biosciences Inc.)|THTX: Company Total Assets|AVTX (Avalo Therapeutics Inc) - Aggregate Company Assets|ELDN (Eledon Pharmaceuticals) - Company Total Assets|agenusbio.com (AGEN) - Company Total Asset Base|Aggregate Company Assets Climb Bio (CLYM)|ZURA - Company Assets|Aggregate Company Assets aTyr ATYR|ADAG - Cumulative Company Assets|Ikena Oncology, Inc. - Company Total Assets|Company Assets Shattuck Labs, Inc.|EQ: Company Total Assets|Total Business Assets CNTB|IMUX (Immunic Therapeutics) - Company Total Assets|Atara Biotherapeutics Inc (ATRA) - Company Total Asset Base|Company Total Assets IFRX|Cumulative Company Assets x4pharma.com XFOR|Company Total Assets ACET (Adicet Bio, Inc.)|Company Total Assets Celularity Inc CELU|INMB - Aggregate Company Assets|BRNS: Aggregate Company Assets|KZR (Kezar Life Sciences) - Cumulative Company Assets|sabbiotherapeutics.com - Aggregate Asset Value|AKTX (Akari Therapeutics Plc) - Company Total Assets|Enlivex Therapeutics, Ltd. (ENLV) - Company Total Asset Base|Aggregate Company Assets Q32 Bio Inc. (QTTB)|GeoVax Corp - Total Business Assets|Company Total Assets EDSA (Edesa Biotech, Inc.)|IBIO - Cumulative Company Assets|CARM: Cumulative Company Assets|Company Total Asset Base XTL Biopharmaceuticals Ltd XTLB|boltbio.com (BOLT) - Aggregate Company Assets|Company Assets HCW Biologics (HCWB)|APVO (Aptevo Therapeutics, Inc.) - Company Total Assets|Cumulative Company Assets AIM ImmunoTech, Inc. (AIM)|Company Total Assets ADTX|GRI - Company Assets|Company Total Assets XRTX (XORTX)|Company Total Assets Vyome Therapeutics HIND|REVB - Aggregate Company Assets|Total Asset Value of Company INDP|SCNI: Company Total Assets|CalciMedica - Aggregate Asset Value|AFMD (Affimed NV) - Company Total Assets|Company Total Assets Allakos Therapeutics|Aggregate Company Assets HOOKIPA Pharma Inc. (HOOK)|IGMS (igmbio.com) - Aggregate Asset Value|Aggregate Company Assets iTeos Therapeutics, Inc. ITOS|TCBP - Cumulative Company Assets|Third Harmonic Bio, Inc - Company Total Assets